Qiagen NV [QGEN] stock is trading at $46.07, up 3.95%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The QGEN shares have gain 6.42% over the last week, with a monthly amount glided 5.28%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Qiagen NV [NYSE: QGEN] stock has seen the most recent analyst activity on December 10, 2024, when Jefferies upgraded its rating to a Buy and also boosted its price target to $54 from $42.50. Previously, HSBC Securities downgraded its rating to Hold on October 17, 2024, and kept the price target unchanged to $49. On June 27, 2024, upgrade upgraded it’s rating to Outperform but maintained its price target of $50 on the stock. Wells Fargo started tracking the stock assigning a Equal Weight rating and suggested a price target of $44 on December 19, 2023. Wolfe Research initiated its recommendation with a Peer Perform. Goldman upgraded its rating to Buy for this stock on December 07, 2023, but kept the price target unchanged to $50. In a note dated September 12, 2023, Robert W. Baird initiated an Outperform rating and provided a target price of $50 on this stock.
Qiagen NV [QGEN] stock has fluctuated between $39.03 and $47.44 over the past year. Currently, Wall Street analysts expect the stock to reach $48.33 within the next 12 months. Qiagen NV [NYSE: QGEN] shares were valued at $46.07 at the most recent close of the market. An investor can expect a potential return of 4.91% based on the average QGEN price forecast.
Analyzing the QGEN fundamentals
Qiagen NV [NYSE:QGEN] reported sales of 1.97B for the trailing twelve months, which represents a growth of 5.46%. Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.05%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.03 and Total Capital is 0.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.54.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 45.47 points at the first support level, and at 44.86 for the second support level. However, for the 1st resistance point, the stock is sitting at 46.67, and for the 2nd resistance point, it is at 47.26.
Ratios To Look Out For
For context, Qiagen NV’s Current Ratio is 2.17. In addition, the Quick Ratio stands at 1.89 and the Cash Ratio stands at 0.86. Considering the valuation of this stock, the price to sales ratio is 5.20, the price to book ratio is 2.90 and price to earnings (TTM) ratio is 114.12.
Transactions by insiders
Recent insider trading involved Sackers Roland, Officer, that happened on Sep 11 ’24 when 25000.0 shares were purchased.